Clinical Trial Update: FDG PET/CT in Breast Cancer Bone Mets

View source ↗

Summary

A study evaluating FDG PET/CT imaging in estrogen receptor-positive breast cancer with bone metastases is currently active but not recruiting. The sponsor is Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer

Snippet

Sponsor: University of Pennsylvania | Conditions: Estrogen Receptor Positive Breast Cancer, Bone Metastases | Status: ACTIVE_NOT_RECRUITING